Carbidopa | Health Canada | Drug Product Database | DPD | PharmaCompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
Drugs in Dev.
News
Blog
Market Place
Login

Carbidopa
Canada

EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

Contact Supplier

SPI Pharma has been solving formulation challenges using superior functional materials.

Contact Supplier

Interquim comes from an international group of 50 companies active in the pharma, hospital, diagnostics, fine chemicals & feed sectors.

Contact Supplier

Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.

Contact Supplier

FAMAR CDMO- From early development to commercial manufacturing.

Contact Supplier

Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

Contact Supplier

Carbidopa

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

39 API Suppliers, 20 USDMF, 17 CEP/COS, 8 JDMF, 1 EU WC, 7 KDMF, 14 NDC API, 18 Listed Suppliers, $ API Reference Price

39 API Suppliers
20 USDMF
17 CEP/COS
8 JDMF
1 EU WC
7 KDMF
14 NDC API
18 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

29 Drugs in Development

29 Drugs in Development

FINISHED DOSAGE FORMULATIONS

344 FDF Dossiers, 118 FDA Orange Book, 167 Europe, 18 Canada, 12 South Africa, 29 Listed Dossiers

344 FDF Dossiers
118 FDA Orange Book
167 Europe
18 Canada
12 South Africa
29 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - 10MG;100MG, TABLET;ORAL - 25MG;100MG, TABLET;ORAL - 25MG;250MG, TABLET;ORAL - 25MG, TABLET, EXTENDED RELEASE;ORAL - 25MG;100MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET, EXTENDED RELEASE;ORAL - 50MG;200MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, CAPSULE, EXTENDED RELEASE;ORAL - 23.75MG;95MG, CAPSULE, EXTENDED RELEASE;ORAL - 36.25MG;145MG, CAPSULE, EXTENDED RELEASE;ORAL - 48.75MG;195MG, CAPSULE, EXTENDED RELEASE;ORAL - 61.25MG;245MG, TABLET;ORAL - 12.5MG;200MG;50MG, TABLET;ORAL - 18.75MG;200MG;75MG, TABLET;ORAL - 25MG;200MG;100MG, TABLET;ORAL - 31.25MG;200MG;125MG, TABLET;ORAL - 37.5MG;200MG;150MG, TABLET;ORAL - 50MG;200MG;200MG

TABLET;ORAL - 10MG;100MG
TABLET;ORAL - 25MG;100MG
TABLET;ORAL - 25MG;250MG
TABLET;ORAL - 25MG
TABLET, EXTENDED RELEASE;ORAL - 25MG;100MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET, EXTENDED RELEASE;ORAL - 50MG;200MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
CAPSULE, EXTENDED RELEASE;ORAL - 23.75MG;95MG
CAPSULE, EXTENDED RELEASE;ORAL - 36.25MG;145MG
CAPSULE, EXTENDED RELEASE;ORAL - 48.75MG;195MG
CAPSULE, EXTENDED RELEASE;ORAL - 61.25MG;245MG
TABLET;ORAL - 12.5MG;200MG;50MG
TABLET;ORAL - 18.75MG;200MG;75MG
TABLET;ORAL - 25MG;200MG;100MG
TABLET;ORAL - 31.25MG;200MG;125MG
TABLET;ORAL - 37.5MG;200MG;150MG
TABLET;ORAL - 50MG;200MG;200MG

RELATED EXCIPIENT COMPANIES

2 EUROAPI, 1 Minakem, 4 Evonik, 4 Rochem International Inc, 21 SPI Pharma, 2 Seqens, 5 DKSH, 7 Faran Shimi Pharmaceutical, 8 Boai NKY Pharmaceuticals Ltd, 1 Chynops Pharma, 8 Gangwal Healthcare, 5 Nanjing Well Pharmaceutical, 2 Pfanstiehl, 1 Capital Farma, 1 Pramukh Pharmachem, 1 ACG Worldwide, 8 Actylis, 1 Aeon Procare, 2 Alcedo Pharmachem, 10 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 29 BASF, 12 Corel Pharma Chem, 6 DFE Pharma, 1 Finar, 12 Gangwal Chemicals, 11 Ideal Cures Pvt Ltd, 5 Ingredion Pharma Solutions, 33 Kerry, 5 Kima Chemical, 6 Lonza Capsugel, 17 Microlex e.U, 1 Nanjing Bold Chemical, 1 NEWEDGE Overseas, 2 Nomisma Healthcare, 4 Novo Excipients, 5 Pharmatrans-Sanaq, 8 Pluviaendo, 5 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Qualicaps, 29 Roquette, 13 Seppic, 7 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shanghai Welltone Material Technology Co., Ltd, 2 Shijiazhuang Huaxu Pharmaceutical, 12 Sigachi Industries, 4 The Dow Chemical Company, 2 Ulanqab Kema New Material, 4 Vasa Pharmachem, 1 Vertellus, 1 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

87 Fillers, Diluents & Binders, 65 Coating Systems & Additives, 47 Disintegrants & Superdisintegrants, 38 Controlled & Modified Release, 36 Direct Compression, 34 Solubilizers, 31 Granulation, 31 Thickeners and Stabilizers, 26 Taste Masking, 23 Parenteral, 23 Film Formers & Plasticizers, 22 Chewable & Orodispersible Aids, 22 Lubricants & Glidants, 17 Co-Processed Excipients, 14 Topical, 8 API Stability Enhancers, 8 Emulsifying Agents, 7 Rheology Modifiers, 5 Coloring Agents, 5 Empty Capsules, 4 Surfactant & Foaming Agents, 4 Vegetarian Capsules, 1 Soft Gelatin

87 Fillers, Diluents & Binders
65 Coating Systems & Additives
47 Disintegrants & Superdisintegrants
38 Controlled & Modified Release
36 Direct Compression
34 Solubilizers
31 Granulation
31 Thickeners and Stabilizers
26 Taste Masking
23 Parenteral
23 Film Formers & Plasticizers
22 Chewable & Orodispersible Aids
22 Lubricants & Glidants
17 Co-Processed Excipients
14 Topical
8 API Stability Enhancers
8 Emulsifying Agents
7 Rheology Modifiers
5 Coloring Agents
5 Empty Capsules
4 Surfactant & Foaming Agents
4 Vegetarian Capsules
1 Soft Gelatin

DIGITAL CONTENT

1 DATA COMPILATION #PharmaFlow, 72 NEWS #PharmaBuzz

1 DATA COMPILATION #PharmaFlow
72 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

9 US Medicaid Prescriptions, 150 Finished Drug Prices, 11 Annual Reports

9 US Medicaid Prescriptions
150 Finished Drug Prices
11 Annual Reports

MARKET PLACE

13 APIs, 9 FDF Dossiers

13 APIs
9 FDF Dossiers

PATENTS & EXCLUSIVITIES

133 US Patents, 4 US Exclusivities

133 US Patents
4 US Exclusivities

REF. STANDARDS & IMPURITIES

3 EDQM, 2 USP, 1 JP, 7 Others

3 EDQM
2 USP
1 JP
7 Others

ANALYTICAL

1 BioAnalytical Methods

1 BioAnalytical Methods

$ API Ref.Price (USD/KG) : 361 Xls

Filters

Reset all filters

Filters

FILTER :

filter Applicant Reset all filters

18 All

01 2AA PHARMA INC

02 3APOTEX INC

03 3AURO PHARMA INC

04 1MINT PHARMACEUTICALS INC

05 2Pharmascience Inc.

06 5SANDOZ CANADA INCORPORATED

07 2TEVA CANADA LIMITED

filter Active Ingredients Reset all filters

18 All

01 16CARBIDOPA

02 2Carbidopa

filter Dosage Form Reset all filters

18 All

01 14TABLET

02 4TABLET (EXTENDED-RELEASE)

filter Brand Name Reset all filters

18 All

01 2AA-LEVOCARB CR

02 3APO-LEVOCARB

03 3AURO-LEVOCARB

04 1MINT-LEVOCARB

05 2PMS-LEVOCARB CR

06 5STALEVO

07 2TEVA-LEVOCARBIDOPA

List of Suppliers

Product Main Page

01

AA PHARMA INC

BioAsia

Not Confirmed

AA PHARMA INC

BioAsia

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info :

Registration Country : Canada

Brand Name : AA-LEVOCARB CR

Dosage Form : TABLET (EXTENDED-RELEASE)

Dosage Strength : 50MG

Packaging : 100

Approval Date :

Application Number : 2245211

Regulatory Info :

Registration Country : Canada

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

02

AA PHARMA INC

BioAsia

Not Confirmed

AA PHARMA INC

BioAsia

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info :

Registration Country : Canada

Brand Name : AA-LEVOCARB CR

Dosage Form : TABLET (EXTENDED-RELEASE)

Dosage Strength : 25MG

Packaging : 100

Approval Date :

Application Number : 2272873

Regulatory Info :

Registration Country : Canada

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

03

APOTEX INC

The Generic Rx Session

Not Confirmed

APOTEX INC

The Generic Rx Session

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info :

Registration Country : Canada

Brand Name : APO-LEVOCARB

Dosage Form : TABLET

Dosage Strength : 10MG

Packaging : 100

Approval Date :

Application Number : 2195933

Regulatory Info :

Registration Country : Canada

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

04

APOTEX INC

The Generic Rx Session

Not Confirmed

APOTEX INC

The Generic Rx Session

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info :

Registration Country : Canada

Brand Name : APO-LEVOCARB

Dosage Form : TABLET

Dosage Strength : 25MG

Packaging : 100/500

Approval Date :

Application Number : 2195968

Regulatory Info :

Registration Country : Canada

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

05

APOTEX INC

The Generic Rx Session

Not Confirmed

APOTEX INC

The Generic Rx Session

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info :

Registration Country : Canada

Brand Name : APO-LEVOCARB

Dosage Form : TABLET

Dosage Strength : 25MG

Packaging : 100/500

Approval Date :

Application Number : 2195941

Regulatory Info :

Registration Country : Canada

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

06

Pharmascience Inc.

BioAsia

Not Confirmed

Pharmascience Inc.

BioAsia

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info : Prescription

Registration Country : Canada

Brand Name : PMS-LEVOCARB CR

Dosage Form : TABLET (EXTENDED-RELEASE)

Dosage Strength : 25MG

Packaging : 100

Approval Date :

Application Number :

Regulatory Info : Prescription

Registration Country : Canada

Portfolio PDF

Product Web Link

Digital Content

07

Pharmascience Inc.

BioAsia

Not Confirmed

Pharmascience Inc.

BioAsia

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info : Prescription

Registration Country : Canada

Brand Name : PMS-LEVOCARB CR

Dosage Form : TABLET (EXTENDED-RELEASE)

Dosage Strength : 50MG

Packaging : 100/500

Approval Date :

Application Number :

Regulatory Info : Prescription

Registration Country : Canada

Portfolio PDF

Product Web Link

Digital Content

08

SANDOZ CANADA INCORPORATED

BioAsia

Not Confirmed

SANDOZ CANADA INCORPORATED

BioAsia

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info :

Registration Country : Canada

Brand Name : STALEVO

Dosage Form : TABLET

Dosage Strength : 18.75MG

Packaging :

Approval Date :

Application Number : 2337827

Regulatory Info :

Registration Country : Canada

Product Web Link

Digital Content

09

TEVA CANADA LIMITED

BioAsia

Not Confirmed

TEVA CANADA LIMITED

BioAsia

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info :

Registration Country : Canada

Brand Name : TEVA-LEVOCARBIDOPA

Dosage Form : TABLET

Dosage Strength : 25MG

Packaging : 100/500

Approval Date :

Application Number : 2244495

Regulatory Info :

Registration Country : Canada

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

10

TEVA CANADA LIMITED

BioAsia

Not Confirmed

TEVA CANADA LIMITED

BioAsia

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info :

Registration Country : Canada

Brand Name : TEVA-LEVOCARBIDOPA

Dosage Form : TABLET

Dosage Strength : 25MG

Packaging : 100/500

Approval Date :

Application Number : 2244496

Regulatory Info :

Registration Country : Canada

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

1
2

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
ASK US!